The current status of HPV DNA testing

European Journal of Gynaecological Oncology

Volumn 24, Issue 5, 2003, Pages 351-356

  Agnantis, N J ^a   Sotiriadis, A ^b   Paraskevaidis, E ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NONE

Author keywords

Follow up; HPV; Hybrid Capture; PCR; Screening; Triage

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER INVASION; CANCER SCREENING; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; HUMAN; MOLECULAR HYBRIDIZATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0141884002     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Macgregor J.E., Campbell M.K., Mann E.M., Swanson K.Y.: "Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease". Br. Med. J., 1994, 308 (6941), 1407.
2. Parkin D.M., Pisani P., Ferlay J.: "Global cancer statistics". CA Cancer J. Clin., 1999, 49 (1), 33, 1.
3. Fahey M.T., Irwig L., Macaskill P.: "Meta-analysis of Pap test accuracy". Am. J. Epidemiol., 1995, 141 (7), 680.
4. Lörincz A.T., Reid R., Jenson A.B., Greenberg M.D., Lancaster W., Kurman R.J.: "Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types". Obstet. Gynecol., 1992, 79 (3), 328.
5. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189 (1), 12.
6. van Muyden R.C., ter Harmsel B.W., Smedts F.M., Hermans J., Kuijpers J.C., Raikhlin N.T. et al.: "Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study". Cancer, 1999, 85 (9), 2011.
7. Schiffman M.H., Brinton L.A.: "The epidemiology of cervical carcinogenesis". Cancer, 1995, 76 (suppl. 10), 1888.
8. Bosch F.X., Munoz N.: "The viral etiology of cervical cancer". Virus Res., 2002, 89 (2), 183.
9. Elfgren K., Bistoletti P., Dillner L., Walboomers J.M., Meijer C.J., Dillner J.: "Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens". Am. J. Obstet. Gynecol., 1996, 174 (3), 937.
10. de Villiers E.M., Wagner D., Schneider A., Wesch H., Miklaw H., Wahrendorf J. et al.: "Human papillomavirus infections in women with and without abnormal cervical cytology". Lancet, 1987, 2 (8561), 703.
11. Lazcano-Ponce E., Herrero R., Munoz N., Cruz A., Shah K.V., Alonso P. et al.: "Epidemiology of HPV infection among Mexican women with normal cervical cytology". Int. J. Cancer, 2001, 91 (3), 412.
12. Depuydt C.E., Vereecken A.J., Salembier G.M., Vanbrabant A.S., Boels L.A. et al.: "Thin-layer liquid based cervical cytology and PCR for detecting and typing human papillomaviruw DNA in Flemish women". Br. J. Cancer, 2003, 88 (4), 560.
13. Reid R., Lörincz A.T.: "Human papillomavirus tests". Baillieres Clin. Obstet. Gynaecol., 1995, 9 (1), 65.
14. Chua K.L., Wiklund F., Lenner P., Angstrom T., Hallmans G., Bergman F. et al.: "A prospective study on the risk of cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears". Int. J. Cancer, 1996, 68 (1), 54.
15. Olsen A.O., Dillner J., Gjoen K., Sauer T., Orstavik I., Magnus P.: "A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix", Int. J. Cancer, 1996, 68 (4), 415.
16. Sun Y., Eluf-Neto J., Bosch EX., Munoz N., Walboomers J.M., Meijer C.J. et al.: "Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma". Cancer Epidemiol. Biomarkers Prev., 1999, 8 (10), 935.
17. Ferris D.G., Wright T.C. Jr., Litaker M.S., Richart R.M., Lörincz A.T., Sun X.W. et al.: "Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and SIL". J. Fam. Pract., 1998, 46 (2), 136.
18. Lörincz A.T.: "Molecular methods for the detection of human papillomavirus infection". Obstet. Gynecol. Clin. N. A., 1996, 23 (3), 707.
19. (No authors listed). "Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group". J. Natl. Cancer Inst., 2000, 92 (5), 397.
20. Venturoli S., Cricca M., Bonvicini F., Giosa F., Pulvirenti F.R. Galli C. et al.: "Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results". J. Clin. Virol., 2002, 25, 177.
21. American College of Obstetricians and Gynecologists: "ACOG technology assessment in Obstetrics and Gynecology". Number 2, December 2002. American College of Obstetricians and Gynecologists. Obstet. Gynecol., 2002, 100 (6), 1423.
22. Agency for Health Care Policy and Research. Evaluation of cervical cytology. Evidence Report/Technology Assessment 5. Rockville (MD): AHCPR; 1999. Publication no. 99-E010.
23. Jones B.A., Novis D.A.: "Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories". Arch. Pathol. Lab. Med., 1996, 120 (6), 523.
24. Ronnett B.M., Manos M.M., Ransley J.E., Fetterman B.J., Kinney W.K., Hurley L.B. et al.: "Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection". Hum. Pathol., 1999, 30 (7), 816.
25. Lonky N.M., Sadeghi M., Tsadik G.W., Petitti D.: "The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results". Am. J. Obstet. Gynecol., 1999, 181, 560.
26. Hong I.S., Marshalleck J., Williams R.H., Gaiter T.E., Mielzynska-Lohnas I., Kim K.: "Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases". Acta Cytol., 2002, 46 (5), 828.
27. Rosendaal L., Walboomers J.M.M., van der Linden J.C., Voorhorst F.J., Kenemans P., Helmerhorst T.H.J.M. et al.: "PCR based high risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervi smears". Int. J. Cancer, 1996, 68, 766.
28. Paraskevaidis E., Davidson E.J., Malamou-Mitsi V., Hirsch P.M., Pappa L., Koliopoulos G., Lolis E., Zikopoulos K., Paschopoulos M., Doussias V., Agnantis N.: "An observational study of women with positive HPV-DNA tests and normal cytology and colposcopy". Eur. J. Gynaecol. Oncol., 2002, 23 (4), 320.
29. Carozzi F., Ronco G., Confortini M., Noferini D., Maddau C., Ciatto S. et al.: "Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing". Br. J. Cancer, 2000, 83 (11), 1462.
30. Schneider A., Hoyer H., Lotz B., Leistritza S., Kuhne-Heid R., Nindl I. et al.: "Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy". Int. J. Cancer, 2000, 89 (6), 529.
31. Ratnam S., Franco E.L., Ferenczy A.: "Human papillomavirus testing for primary screening of cervical cancer precursors". Cancer Epidemiol. Biomarkers. Prev., 2000, 9 (9), 945.
32. Kuhn L., Denny L., Pollack A., Lörincz A., Richart R.M., Wright T.C.: "Human papillomavirus DNA testing for cervical cancer screening in low-resource settings". J. Natl. Cancer Inst., 2000, 92 (10), 818.
33. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M. et al.: "Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women". Br. J. Cancer, 2001, 84 (12), 1616.
34. Kulasingam S.L., Hughes J.P., Kiviat N.B., Mao C., Weiss N.S., Kupers J.M. et al.: "Evaluation of human papillomavirus testing in primary screening for cervical abnormalities". JAMA, 2002, 288 (14), 1749.
35. Paraskevaidis E., Malamou-Mitsi V., Koliopoulos G., Pappa L., Lolis E., Georgiou I., Agnantis N.J.: "Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing". Gynecol. Oncol., 2001, 82 (2), 355.
36. Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S. et al.: "HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica". JAMA, 2000, 283 (1), 87.
37. Goldie S.J., Kuhn L., Denny L., Pollack A., Wright T.C.: "Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness". JAMA, 2001, 285 (24), 3107.
38. Lytwyn A., Sellors J.W., Mahony J.B., Daya D., Chapman W., Ellis N. et al.: "Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group". CMAJ, 2000, 163 (6), 701.
39. Solomon D., Schiffman M., Tarone R., ALTS Study group: "Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial". J. Natl. Cancer Inst., 2001, 93 (4), 293.
40. Kim J.J., Wright T.C., Goldie S.J.: "Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance". JAMA, 2002, 287 (18), 2382.
41. Wright T.C. Jr., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J., ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA, 2002, 287 (16), 2120.
42. Martin-Hirsch P.L., Paraskevaidis E., Kitchener H.: "Surgery for cervical intraepithelial neoplasia (Cochrane Review)". In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software.
43. Soutter W.P., de Barros Lopes A., Fletcher A., Monaghan J.M., Duncan I.D., Paraskevaidis E. et al.: "Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia". Lancet, 1997, 349 (9057), 978.
44. Paraskevaidis E., Koliopoulos G., Alamanos Y., Malamou-Mitsi V., Lolis E.D., Kitchener H.C.: "Human Papillomavirus testing in the prediction of the outcome of treatment for cervical intraepithelial neoplasia". Obstet. Gynecol., 2001, 98 (5 Pt 1), 833.
45. Paraskevaidis E., Lolis E.D., Koliopoulos G., Alamanos Y., Fotiou S., Kitchener H.C.: "Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins". Obstet. Gynecol., 2000, 95 (6 Pt 1), 828.
46. Paraskevaidis E., Kalantaridou S.N., Paschopoulos M., Zikopoulos K., Lolis E.D., Dalkalitsis N. et al.: "Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia". Eur. J. Gynaecol. Oncol., 2003 (in press).
47. Elfgren K., Jacobs M., Walboomers J.M., Meijer C.J., Dillner J.: "Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia". Obstet. Gynecol., 2002, 100 (5 Pt 1), 965.
48. Paraskevaidis E., Kitchener H., Adonakis G., Parkin D., Lolis D.: "Incomplete excision of CIN in conization: further excision or conservative management?". Eur. J. Obstet. Gynecol. Reprod. Biol., 1994, 53 (1), 45.
49. Chua K.L., Hjerpe A.: "Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri". Gynecol. Oncol., 1997, 66 (1), 108.
50. DiStefano A.L., Picconi M.A., Alonio L.V., Dalbert D., Mural J., Bartt O. et al.: "Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision". Infect. Dis. Obstet. Gynecol., 1998, 6 (5), 214.
51. Bollen L.J., Tjong-A-Hung S.P., van der Velden J., Mol B.W., ten Kate F.W., ter Schegget J. et al.: "Prediction of recurrent and residual dysplasia by human papillomavirus detection among patients with abnormal cytology". Gynecol. Oncol., 1999, 72 (2), 199.
52. Nagai Y., Maehama T., Asato T., Kanazawa K.: "Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?". Gynecol. Oncol., 2000, 79 (2), 294.
53. Kjellberg L., Wadell G., Bergaman F., Isaksson M., Angstrom T., Dillner J.: "Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser". Am. J. Obstet. Gynecol., 2000, 183 (5), 1238.
54. Lin C.T., Tseng C.J., Lai C.H., Hsueh S., Huang K.G., Huang H.J. et al.: "Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen". Am. J. Obstet. Gynecol., 2001, 184 (5), 940.
55. Nobbenhuis M.A.E., Meijer C.J.L.M., van der Brule A.J.C., Rozendaal L., Voorhorst F.J., Risse E.K. et al.: "Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia". Br. J. Cancer, 2001, 84 (6), 796.
56. Kucera E., Sliutz G., Czervenka K., Breitenecker G., Leodolter S., Reinthaller A.: "Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 100 (1), 72.
57. Acladious N., Sutton C.J., Mandal D., Zaklama M., Hopkins R., Kitchener H.C.: "Persistent human papillomavirus infection and smoking increase risk of failure of treatment of CIN". Int. J. Cancer, 2002, 98 (3), 435.